Business profile & competitive position
Ulta Beauty, Inc. operates in the Consumer Cyclical sector and Specialty Retail industry as the largest U.S. specialty beauty retailer. Its core business is a differentiated assortment of cosmetics, fragrance, skin care, wellness products, hair care products, and salon services, sold across a wide range of price points through stores, websites, mobile applications, and partnerships. The company also has international reach through its Space NK subsidiary in the U.K. and Ireland, a Mexico joint venture, and a Middle East franchise.
The financial signatures of the business are a 9.3% net margin and a 45.4% return on equity. A net margin above 9% is relatively healthy for specialty retail, where price competition and promotional activity are usually intense. The 45.4% ROE indicates strong capital efficiency, likely supported by the company’s loyalty-driven repeat business. At the end of fiscal 2025, Ulta U.S. had more than 46 million loyalty-program members, and approximately 95% of total sales came from those members. Within that base, 73% of loyalty members transacted solely in stores, while omnichannel members historically spent more than three times as much as store-only members. That data pattern suggests the real competitive asset is not a traditional defensive moat, but a high-frequency, data-rich loyalty platform that lowers customer-acquisition costs and supports repeat purchasing.
Financial posture
As of the current snapshot, Ulta carries a market capitalization of $23.5 billion and trades at a price-to-earnings ratio of 19.8. A P/E of 19.8 sits in the broad midrange for a consumer discretionary retailer: it is not deeply discounted and does not obviously price in hypergrowth. The 9.3% net margin provides a meaningful buffer for operating leverage, while the 45.4% ROE reflects either strong profitability or meaningful financial leverage, or a combination of both. The stock’s beta is 0.85, meaning it has historically moved less than the overall market on a percentage basis. The current price is $546.2932, RSI is 52.4, and the 50-day exponential moving average is $533.00, so price is sitting just above the medium-term moving average with neutral short-term momentum. No debt figures are supplied in the current data set, so leverage cannot be independently assessed here.
Strategic priorities & outlook
Ulta’s most recent 10-K filing outlines three operational priorities. The first is to drive core business growth through operational excellence and an elevated go-to-market approach. That is framed around best-in-class store execution, digital acceleration, brand building and merchandising innovation, and enhanced marketing and personalization. The second priority is to scale newer, accretive businesses, specifically wellness, UB Marketplace, international expansion, and UB Media. The third is to align the foundation for future success by optimizing ways of working, streamlining the cost structure, and cultivating an associate-centered culture.
On the footprint side, Ulta U.S. operated more than 1,500 retail stores as of January 31, 2026, and management believes the long-term U.S. footprint can reach more than 1,800 freestanding locations. That implies a still-positive domestic store-growth runway. Two notable operational changes are the mutual decision with Target not to renew the Ulta Beauty at Target shop-in-shop partnership beyond August 2026, and the launch of UB Marketplace in fiscal 2025. The Space NK acquisition was completed on July 10, 2025, giving the company a direct platform in the U.K. and Ireland beauty market.
Macro & geopolitical exposure
As a Consumer Cyclical Specialty Retailer, Ulta’s demand is tied to discretionary spending. The business is exposed to changes in consumer confidence, employment levels, and disposable income, because beauty and salon purchases can be pulled forward or deferred depending on household budgets.
Beyond the demand cycle, the sector classification implies additional exposures. Cosmetics, skin care, and fragrance often involve imported ingredients, components, or finished goods, so tariffs and trade policy can affect cost of goods sold. International operations — specifically Space NK in the U.K. and Ireland, the Mexico joint venture, and the Middle East franchise — create foreign-exchange translation and local competitive risk. Regulatory scrutiny of cosmetics ingredients, packaging standards, and animal-testing rules varies by country and can change product availability or compliance costs. The Middle East franchise also carries regional geopolitical risk. Supply-chain reliability for a broad SKU assortment, plus store labor and commercial real estate costs, round out the standard macro and industry-level risk set for this type of retailer.
Recent developments
News flow around the stock has been positive in the run-up to the next report. On September 30, 2026, Zacks reported that Ulta Beauty raised its 2026 outlook as e-commerce momentum accelerated. The same day, another Zacks article asked whether UltaBeauty was worth buying as growth met a midrange valuation, and a third noted the stock had risen 20.7% over the prior three months. On October 5, 2026, Zacks included Ulta in a list of two retail and wholesale stocks that could beat earnings. These headlines suggest third-party analysts were focused on the combination of raised guidance, digital growth, and the recent 20.7% price rally rather than on new negative fundamental disclosures.
Earnings behavior & post-earnings drift
Over the last eight reported quarters, Ulta has beaten earnings estimates seven times, for an 88% beat rate, and the average earnings surprise has been 11.1%. Despite that strong beat record, the average five-day price move after those reports has been -0.91%, classified as a downward post-earnings drift. That is a notable dynamic: the company usually exceeds the official consensus, but the market reaction is often contained or negative once the results are in.
The most recent quarters illustrate the pattern. On August 27, 2026, Ulta reported EPS of $6.55 against an estimate of $6.22, a 5.3% positive surprise, yet the stock fell 4.18% the next day before gaining 3.15% over the following five days. On June 2, 2026, EPS came in at $7.74 versus $6.89, a 12.3% beat, but the stock dropped 4.78% the next day and 3.43% over the next five days. The one negative quarter in the last four was March 12, 2026, when EPS of $8.01 missed the $8.10 estimate by 1.1%; the stock sold off 14.24% the next day and 14.50% over the next five days. By contrast, the December 4, 2025 report delivered EPS of $5.14 versus $4.61, an 11.5% beat, and the stock rallied 12.65% the next day and 11.14% over five days. The next scheduled earnings release is December 3, 2026, after the market close, with a consensus EPS estimate of $5.60.
Frequently Asked Questions
What does Ulta’s 45.4% ROE say about its competitive position?
The 45.4% ROE points to strong capital efficiency, but in specialty retail that is usually driven by a combination of profitability, leverage, and a high-frequency loyalty model rather than by a wide defensive moat. The 46-million-member loyalty program and the fact that 95% of sales come from members are the more relevant competitive datapoints.
Why has Ulta’s post-earnings drift been slightly negative despite frequent beats?
Over the last eight quarters Ulta has beaten 88% of the time with an average 11.1% positive surprise, yet the average five-day post-earnings move is -0.91%. That suggests expectations may be elevated and that even solid beats can be priced in, while any disappointment can be punished, as seen in the 14.24% one-day drop after the March 2026 miss.
What macro factors are most relevant to Ulta as a specialty beauty retailer?
Because Ulta sits in Consumer Cyclical/Specialty Retail, the most relevant macro exposures are discretionary consumer spending, employment and confidence trends, foreign exchange from its U.K., Mexico, and Middle East operations, tariffs or trade restrictions on imported beauty products, and evolving cosmetics regulation across multiple jurisdictions.
For a deeper dive into how institutional analysts are weighing these metrics, strategic shifts, and earnings dynamics ahead of the December 3 report, review the full institutional verdict on Ulta Beauty.
| Reported | Actual | Estimate | Surprise | 1D Move | 5D Move |
|---|---|---|---|---|---|
| 2026-08-27 | $6.55 | $6.22 | +5.3% | -4.18% | +3.15% |
| 2026-06-02 | $7.74 | $6.89 | +12.3% | -4.78% | -3.43% |
| 2026-03-12 | $8.01 | $8.1 | -1.1% | -14.24% | -14.5% |
| 2025-12-04 | $5.14 | $4.61 | +11.5% | +12.65% | +11.14% |
| 2025-08-28 | $5.78 | $5.1 | +13.3% | - | - |
| 2025-05-29 | $6.7 | $5.81 | +15.3% | - | - |
Previous ULTA editions
Get the institutional verdict on ULTA
Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.
Read the ULTA verdict at Gamma QCVerify authenticity
Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.